Skip to main content

Table 1 The base case analysis for all the strategies with ‘days until the first event (myocardial infarction, stroke or death)’ as the health outcome and cost until death

From: Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data

Strategies

Number of pairs included in the strategy

Time free of event in days for participants mean (SE)

Time free of events in controls mean (SE)

Difference of days free of event per pair mean (SE)

Difference in time free of event in days study population (SE)

Difference of costs per pair in €* mean (SE)

Difference in cost in €* study population (SE)

ICER (€/year)

KardioPro for all risk groups

13,112

629.56

629.39

3.17

41,514

674.35

8,842,036

77,742

(1.62)

(1.65)

(0.84)

(11,070)

(133.82)

(1,754,657)

KardioPro for CHD group

1,411

599.35

592.81

6.54

9,226

473.92

668,696

26,456

(4.95)

(5.17)

(4.42)

(6,238)

(607.67)

(857,428)

KardioPro for high-risk group

964

606.33

595.77

10.56

10,182

604.79

583,014

20,901

(5.80)

(6.02)

(4.29)

(4,136)

(555.02)

(535,035)

KardioPro for medium-risk group

1,729

604.94

599.13

5.81

10,041

832.47

1,439,334

52,323

(4.29)

(4.40)

(2.62)

(4,537)

(425.73)

(736,090)

KardioPro for low-risk group

9,008

641.50

640.16

1.34

12,066

682.84

6,150,992

186,074

(1.96)

(1.98)

(0.74)

(6,694)

(138.69)

(1,249,335)

KardioPro for CHD and high- and medium-risk group

4,104

603.34

596.17

7.18

29,558

655.71

2,690,846

33,251

(2.83)

(2.93)

(2.13)

(8,761)

(304.32)

(1,261,563)

KardioPro for CHD and high-risk group

2,375

602.18

594.01

8.17

19,344

527.04

1,254,061

23,678

(3.77)

(3.93)

(3.16)

(7,501)

(425.34)

(1,000,480)

KardioPro for high- and medium-risk group

2,693

605.44

597.93

7.51

20,241

750.96

2,016,933

36,395

(3.45)

(3.55)

(2.28)

(6,019)

(337.36)

(910,159)

  1. *Only the difference in costs between intervention and control group are displayed, as the absolute values are confidential.
  2. CHD: coronary heart diseases.
  3. ICER: incremental cost-effectiveness ratio.
  4. SE: standard error.
  5. Costs were inflated to the year 2010. Both costs and effects were discounted at 5%.
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us